These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6816716)

  • 1. Diphenoloxidases in various forms of myopathy which are transmitted by different genetic mechanisms.
    Demos JJ; Tuil DG; Katz PC
    Hum Genet; 1982; 61(3):185-9. PubMed ID: 6816716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenoloxidases in X-linked recessive (Duchenne) muscular dystrophy.
    Demos JJ; Tuil DG; Katz PC; Berthelon MA; Dautreaux B; Premont N
    Hum Genet; 1981; 59(2):154-60. PubMed ID: 6799386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet diphenoloxidases in progressive muscular dystrophy (P.M.D.).
    Dèmos J
    Clin Genet; 1973; 4(2):79-90. PubMed ID: 4199873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzymology and myopathy. Diagnostic and genetic value of determination of platelet diphenol-oxydase activity].
    Demos J; Berthelon M
    Arch Fr Pediatr; 1972 Oct; 29(8):793-9. PubMed ID: 4632798
    [No Abstract]   [Full Text] [Related]  

  • 5. Absence of differences in platelet dihydroxyphenylalanine (dopa) oxidase polymorphism in health and Duchenne's muscular dystrophy.
    Pacold I; Morgan J; Cohen L
    Clin Genet; 1975; 7(5):435-41. PubMed ID: 807447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes.
    Sohar I; Laszlo A; Gaal K; Mechler F
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():277-9. PubMed ID: 3202967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte enzyme allotypes in the X-linked recessive disorders, Duchenne muscular dystrophy and haemophilia-A hemizygotes and heterozygotes.
    László A; Kósa F; Zimányi I; Egyed A
    Acta Paediatr Hung; 1985; 26(2):87-96. PubMed ID: 2931091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the carrier state in X-linked recessive (Duchenne) muscular dystrophy.
    Thomson WH; Sweetin JC; Hilditch TE
    Clin Chim Acta; 1975 Sep; 63(3):383-94. PubMed ID: 240524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor unit reorganization in progressive muscular dystrophies and congenital myopathies.
    Szmidt-Sałkowska E; Gaweł M; Lipowska M
    Neurol Neurochir Pol; 2015; 49(4):223-8. PubMed ID: 26188938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium activated neutral protease in blood cells from patients & carriers of Duchenne muscular dystrophy.
    Moses L; Shailaja B; Anandaraj MP
    Indian J Med Res; 1990 Feb; 92():5-8. PubMed ID: 2347611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum LDH-5 in carriers of Duchenne muscular dystrophy.
    Burt D; Emery AE
    Neurology; 1979 Feb; 29(2):239-41. PubMed ID: 571069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 16. [The respiratory function in muscular dystrophies (author's transl)].
    Rideau Y
    Sem Hop; 1980 Jan 8-15; 56(1-2):28-37. PubMed ID: 6244625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.